US Patent Issued to Wyvern Pharmaceuticals on Nov. 4 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,209, issued on Nov. 4, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada).

"Composition for regulating production of interfering ribonucleic acid" was invented by Bradley G. Thompson (Calgary, Canada) and Jillian Thompson (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure relate to a composition that comprises a recombinant plasmid (RP) with a sequence of nucleic acids. The sequence comprise a start region, an end region and an insert positioned between the start region and the end region. The insert encodes for a sequence of micro interfering ribonucleic acid (miRNA) that may be complimen...